Navigation Links
Adhering to Clinical Guidelines Decreases Blood Clots in the Elderly

A multifaceted intervention designed to increase adherence with clinical guidelines for preventing deep-vein blood clots may decrease the rate of such blood clots among// elderly patients, according to a report in the October 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Older adults and those in the hospital are at increased risk for deep vein thrombosis (DVT), a blood clot in the thigh or leg, according to background information in the article. Medications and compression stockings have been shown to reduce or prevent DVT in some patients. “However, several studies demonstrate a gap between scientific evidence and clinical practice in various settings, including post–acute care facilities,” the authors write. “These facilities are used to ensure the transition between short hospital stays and home when patients require specialized care or rehabilitation services.”

Elodie Sellier, M.D., Joseph Fourier University, Grenoble, France, and colleagues studied 1,373 patients age 65 or older (66.9 percent women) enrolled in 33 post–acute care facilities in France. The researchers evaluated patients for DVT before and after they implemented evidence-based guidelines for physicians and nurses at the facilities regarding prevention of DVT. The guidelines recommended that health care providers give prophylactic (preventive) medications to certain patients, such as those who recently had major surgery or who previously had DVT. Physical therapy, compression stockings and other non-drug preventive measures were recommended for other patients or in addition to medications in some cases. Educational sessions were held to communicate the guidelines; physicians and nurses were given posters and plastic cards as reminders. The researchers assessed 709 patients before and 664 patients following the implementation of the guidelines.

Before the guidelines were put in place, a blood clot was found in 91 (12.8 percent) of 709 patients. Following the intervention, clots were found in only 52 (7.8 percent) of 664 patients. The post-intervention participants were more likely to use compression stockings and less likely to take medications that were not recommended by the guidelines, especially if they were patients for whom drug therapy was not recommended under the guidelines.

“Changes in the prophylaxis means measured can only partly explain the decrease in the rate of DVT observed in our study. The most important change in prophylaxis consisted of an increased use of graduated compression stockings, while the change in pharmacologic prophylaxis use was modest and not statistically significant,” the authors write.

“These observations together suggest that our multifaceted intervention not only altered the use of measured prophylaxis means but also improved physician and nurse awareness of patients at risk for venous thromboembolism and eventually increased the use of additional prophylactic measures including early ambulation and physical therapy, which were addressed by our intervention but not investigated in our study,” they continue. Additional efforts should be undertaken to ensure that physicians and nurses comply with evidence-based guidelines for the prevention of DVT, they conclude.

Source-Newswie
SRM
'"/>




Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
8. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
9. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
10. Cancer Clinical Research in India
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: